Evidence map›Paper›PMID 41295861›Full record

ArticleToxins2025

Characterization of

Rim Wehbe, Aline Karaki, Zeina Dassouki, Mohamad Rima, Adolfo Borges, Rabih Roufayel, Christian Legros, Ziad Fajloun, Zakaria Kambris

Abstract read
In one paragraph

Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rim WehbeBiology Department, Faculty of Arts and Sciences, American University of Beirut, Beirut 1107 2020, Lebanon.
Aline KarakiBiology Department, Faculty of Arts and Sciences, American University of Beirut, Beirut 1107 2020, Lebanon.
Zeina DassoukiDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Balamand, Tripoli P.O. Box 100, Lebanon.
Mohamad RimaDepartment of Biological Sciences, Lebanese American University, Byblos P.O. Box 36, Lebanon.ORCID 0000-0002-0335-9882
Adolfo BorgesLaboratorio de Biologia Molecular de Toxinas y Receptores, Instituto de Medicina Experimental, Facultad de Medicina, Universidad Central de Venezuela, Caracas 1050, Venezuela.ORCID 0000-0001-5827-2410
Rabih RoufayelCollege of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.ORCID 0000-0002-4595-1104
Christian LegrosUniv. Angers, INSERM, CNRS, MITOVASC, Equipe CarME, SFR ICAT, 49000 Angers, France.ORCID 0000-0002-3346-7059
Ziad FajlounDepartment of Cell Culture, Laboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and Its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon.ORCID 0000-0002-6502-3110
Zakaria KambrisBiology Department, Faculty of Arts and Sciences, American University of Beirut, Beirut 1107 2020, Lebanon.ORCID 0000-0002-7377-1899

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scorpion venom is a rich source of diverse bioactive molecules with medicinal importance. While the venoms of many Buthidae scorpions have been extensively studied for their toxicity and therapeutic potential,

Indexed as

AedesBehavior, AnimalCulexDrosophila melanogasterInsecticidesScorpion VenomsAnimalsCell Line, TumorHumansLocomotionScorpionsSleepInsecticidesScorpion VenomscytotoxicityDrosophila melanogasterHottentotta judaicusinsecticidal effectslocomotor activitymosquitoesscorpion venomtoxins

Identifiers

PMID41295861
PMCPMC12656134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.